Related Experiment Video
Updated: Jun 1, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Therapeutic options in treatment-resistant depression
1Bipolar Disorders Program, Hospital Clinic, University of Barcelona , Catalonia, Spain. evieta@clinic.ub.es
Annals of Medicine
|June 1, 2011
Summary
Treatment-resistant depression (TRD) affects many patients, with unclear definitions and limited treatments, especially for bipolar depression. Novel therapies are emerging, offering hope beyond traditional approaches.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Medicine
Background:
- Treatment-resistant depression (TRD) is common, defined by inadequate response to standard antidepressants.
- Definitions and treatments for TRD vary, particularly between unipolar and bipolar depression.
- TRD significantly impairs clinical, functional, and social outcomes.
Purpose of the Study:
- To review the current understanding and treatment landscape of treatment-resistant depression.
- To highlight the challenges in defining and managing TRD, especially in bipolar disorder.
- To explore emerging therapeutic strategies for TRD.
Main Methods:
- Literature review of existing definitions and treatment options for TRD.
- Analysis of evidence for pharmacological and non-pharmacological interventions.
- Comparison of treatment approaches for unipolar versus bipolar TRD.
Main Results:
- Lack of consensus on TRD definition persists.
- Limited evidence for bipolar TRD treatments compared to unipolar TRD.
- Novel treatments targeting non-monoamine systems show promise.
- Augmentation, combination therapies, ECT, and DBS are potential options.
- Cognitive behavioral therapy is recommended for unipolar TRD only.
Conclusions:
- TRD poses significant clinical challenges with diverse definitions and treatment gaps.
- Evidence for bipolar TRD management is scarce, necessitating further research.
- Emerging therapies offer new avenues for TRD, requiring validation.
- Personalized treatment strategies are crucial for improving outcomes in TRD.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...